A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

Title
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 22, Issue 2, Pages 319-327
Publisher
American Association for Cancer Research (AACR)
Online
2015-09-17
DOI
10.1158/1078-0432.ccr-15-1443

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search